ICD-10 Coding for Tardive Dyskinesia(G24.0, G24.01, G24.01B)
Learn about ICD-10 coding for tardive dyskinesia, including documentation requirements, common pitfalls, and billing considerations.
Complete code families applicable to Tardive Dyskinesia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G24.01 | Drug-induced subacute dyskinesia | Use for tardive dyskinesia caused by neuroleptic drugs. |
|
| G24.09 | Other drug-induced dyskinesia | Use for atypical presentations of drug-induced dyskinesia. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutTardive Dyskinesia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Tardive Dyskinesia.
Omitting drug exposure duration
Impact
Clinical: Misdiagnosis of movement disorder, Regulatory: Non-compliance with coding standards, Financial: Potential claim denials
Mitigation
Always document drug history and duration, Use templates to ensure completeness
Confusing tardive dyskinesia with Parkinson's dyskinesia
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient care.
Mitigation
Ensure documentation specifies drug-induced cause and duration of exposure.
Inadequate documentation of drug exposure
Impact
Failure to document drug exposure duration can lead to audit issues.
Mitigation
Use standardized templates and checklists to ensure complete documentation.